Healthcare Services

Gastric Cancer Diagnostic Market: Growth Opportunities and Outlook

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Gastric Cancer Diagnostic Procedure Market In 2026 And 2030?

The gastric cancer diagnostic procedure market size has shown robust growth over recent years. It is anticipated to expand from $1.54 billion in 2025 to $1.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the application of endoscopy in gastric diagnosis, the widespread adoption of biopsy procedures, the availability of imaging tests, the presence of hospital-based diagnostic infrastructure, and the ongoing development of pathology laboratories.

The gastric cancer diagnostic procedure market size is anticipated to undergo significant expansion in the foreseeable future. It is projected to achieve a value of $2.23 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 7.7%. This growth during the forecast period is driven by various factors such as the advancements in liquid biopsy techniques, the wider application of molecular diagnostics, the escalating demand for early detection, increased automation in diagnostic workflows, and the emergence of AI-enabled imaging analysis. Prominent trends expected in the forecast period involve the expanding utilization of endoscopic diagnostic techniques, the increasing adoption of molecular and genetic testing, a heightened need for early-stage cancer detection, the growth of non-invasive diagnostic procedures, and the integration of cutting-edge imaging technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Which Important Drivers Are Guiding The Gastric Cancer Diagnostic Procedure Market Growth?

The escalating trend in smoking is anticipated to boost the expansion of the gastric cancer diagnostic procedure market in the future. Smoking is defined as the act of inhaling and exhaling the smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures play a critical role for individuals with a smoking history or those susceptible to smoking-related cancers, facilitating early detection and identification of precancerous lesions, aiding in the development of personalized and tailored treatment plans, enhancing communication and coordination, and offering a comprehensive assessment of the gastric mucosa and surrounding tissues. For instance, in July 2023, a report from the World Health Organization, a Switzerland-based intergovernmental organization, stated that over 8 million people die from tobacco each year, including 1.3 million non-smokers exposed to second-hand smoke. Thus, the increasing surge in smoking is propelling the growth of the gastric cancer diagnostic procedure market.

How Is The Gastric Cancer Diagnostic Procedure Market Broken Down By Segment Categories?

The gastric cancer diagnostic procedure market covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types

2) By Symptom Type: Symptomatic, Asymptomatic

3) By Offering Type: Instruments, Reagents And Consumables, Services

4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid

5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

Subsegments:

1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)

2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy

3) By Tissue Tests: Histopathology, Immunohistochemistry

4) By Lab Tests: Blood Tests, Tumor Markers

5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling

6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan

7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)

8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

10) By Other Procedure Types: Breath Tests, Liquid Biopsies

What Trends Are Influencing The Evolution Of The Gastric Cancer Diagnostic Procedure Market?

Key players in the gastric cancer diagnostic procedure market are concentrating on technological improvements, such as dual cell-free and exosomal miRNA liquid biopsy assays, to achieve a competitive advantage. These assays work by measuring small noncoding RNAs present both freely in the bloodstream and enclosed within tumor-derived exosomes, which facilitates highly sensitive and specific detection of gastric cancer from a basic blood sample. For example, in December 2024, Cizzle Bio, a U.S.-based biotechnology company, unveiled its DEX G2 blood test. This test integrates cell-free and exosomal miRNAs to attain roughly 95% sensitivity and 97% specificity, and it only requires a standard blood draw instead of an invasive endoscopy. This breakthrough holds promise for earlier diagnosis and expanded screening reach, although its widespread acceptance could be limited by regulatory approval schedules and the requirement for real-world validation.

Which Players Are Present In The Gastric Cancer Diagnostic Procedure Market Space?

Major companies operating in the gastric cancer diagnostic procedure market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Myriad Genetics Inc., Foundation Medicine Inc., Biocept Inc., Illumina Inc., Roche Diagnostics, QIAGEN N V, Bio-Rad Laboratories Inc., Siemens Healthineers, Danaher Corporation, Becton Dickinson, bioMérieux SA, PerkinElmer Inc., NeoGenomics Laboratories, Guardant Health Inc., Natera Inc., Caris Molecular Diagnostics, Adaptive Biotechnologies Corp, 10x Genomics Inc

Get The Full Gastric Cancer Diagnostic Procedure Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Where Is The Gastric Cancer Diagnostic Procedure Market Primarily Concentrated By Region?

North America was the largest region in the gastric cancer diagnostics procedure market in 2025. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gastric Cancer Diagnostic Procedure Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Procedure Market 2026, By The Business Research Company

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Gastric Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Ulcers Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795